PFC Capital Group Inc. Sells 1,000 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

PFC Capital Group Inc. reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,000 shares of the company’s stock after selling 1,000 shares during the quarter. PFC Capital Group Inc.’s holdings in GE HealthCare Technologies were worth $625,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Geode Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 3.1% in the 4th quarter. Geode Capital Management LLC now owns 11,320,576 shares of the company’s stock valued at $882,777,000 after purchasing an additional 342,819 shares during the period. Diametric Capital LP acquired a new position in GE HealthCare Technologies during the fourth quarter worth $203,000. Nemes Rush Group LLC raised its stake in GE HealthCare Technologies by 256.7% during the fourth quarter. Nemes Rush Group LLC now owns 849 shares of the company’s stock worth $66,000 after acquiring an additional 611 shares in the last quarter. National Bank of Canada FI boosted its stake in shares of GE HealthCare Technologies by 262.4% in the 4th quarter. National Bank of Canada FI now owns 443,248 shares of the company’s stock valued at $34,661,000 after purchasing an additional 320,924 shares in the last quarter. Finally, Franklin Resources Inc. grew its holdings in shares of GE HealthCare Technologies by 1.7% in the 4th quarter. Franklin Resources Inc. now owns 67,536 shares of the company’s stock worth $5,280,000 after purchasing an additional 1,105 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $80.71 on Tuesday. The firm has a market cap of $36.91 billion, a price-to-earnings ratio of 18.64, a PEG ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a 50-day moving average price of $86.62 and a 200 day moving average price of $85.81.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.23%.

Analysts Set New Price Targets

Several brokerages recently issued reports on GEHC. Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Citigroup increased their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.